期刊文献+

DE方案与CEF方案在乳腺癌新辅助化疗中的作用 被引量:1

下载PDF
导出
摘要 目的:比较DE方案与CEF方案用于局部进展期乳腺癌的疗效及毒性反应。方法:60例III期乳腺癌患者随机分为DE组及CEF组,各30例。完成3个周期化疗后,评定两组疗效及毒性反应。结果:DE组总有效率为83%,CEF组总有效率为56%,差异有统计学意义(P<0.05)。两种方案毒性反应差异无统计学意义(P>0.05)。结论:DE方案与CEF方案均可用于乳腺癌的新辅助化疗,但DE方案疗效高于CEF方案,因此值得进一步推广。
作者 黄秀芳
出处 《医学信息(中旬刊)》 2011年第6期2270-2271,共2页 Medical Information Operations Sciences Fascicule
  • 相关文献

参考文献6

  • 1Beasley GM,Olson JA Jr.What's new in neoadjuvant therapy for breast cancer[J]?Adv Surg,2010,44:199-228.
  • 2Bear HD.Neoadjuvant chemotherapy for operable breast cancer:individualizing locoregional and systemic therapy[J].Surg Oncol Clin N Am,2010,19(3):607-626.
  • 3Chávez-MacGregor M,González-Angulo AM.Breast cancer,neoadjuvant chemotherapy and residual disease[J].Clin Transl Oncol,2010,12(7):461-467.
  • 4Specht J,Gralow JR.Neoadjuvant chemotherapy for locally advanced breast cancer[J].Semin Radiat Oncol,2009,19(4):222-228.
  • 5Mathew J,Asgeirsson KS,Cheung KL,et al.Neoadjuvant chemotherapy for locally advanced breast cancer:a review of the literature and future directions[J].Eur J Surg Oncol,2009,35(2):113-122.
  • 6Kim R,Osaki A,Toge T.Current and future roles of neoadjuvant chemotherapy in operable breast cancer[J].Clin Breast Cancer,2005,6(3):223-232.

同被引文献5

  • 1刘慧,张恒伟,崔树德.新辅助化疗在乳腺癌保乳手术中的应用分析[J].中国误诊学杂志,2007,7(21):4981-4982. 被引量:6
  • 2孙燕,石远凯.临床肿瘤内科手册[M].北京:人民卫生社出版.2007.152.
  • 3Mazouni C, Peintinger F, Wan-Kau S, et al. Residual ductal carci- noma in situ in patients with Complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome [ J ]. J Clin Oncol,2007,25 ( 19 ) :2650.
  • 4Bear HD,Anderson S,Brown A,et al. The efect on tumor response of adding sequential preoperative doeetaxel to preoperative doxoru- bicin and eyclophosphamide:preliminary results from NSABP B-27 [ J ]. J Clin Oneol,2003,21 (22) :4165.
  • 5陈承学,朱强.乳腺癌新辅助化疗的近期疗效分析[J].中国社区医师(医学专业),2012,14(36):164-164. 被引量:7

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部